You are using a browser that is not supported by this site. The site will not function properly. Please switch to the latest version of a supported browser such as Chrome, Safari, Edge, or Firefox to use this site.

Support Every Step of the Way

United Therapeutics offers resources and support for patients who have been prescribed a United Therapeutics PAH therapy.

Personal support from a Specialty Pharmacy

United Therapeutics collaborates with Specialty Pharmacies that are specifically equipped to handle the intricacies of PAH therapy. Specialty Pharmacies provide help such as:

  • Scheduling nurse visits to get patients started with treatment
  • Offering ongoing assistance through in-person or virtual visits and 24-hour phone support
  • Coordinating the delivery of medicine

Personal support from a Specialty Pharmacy

United Therapeutics collaborates with Specialty Pharmacies that are specifically equipped to handle the intricacies of PAH therapy. Specialty Pharmacies provide help such as:

  • Scheduling nurse visits to get patients started with treatment
  • Offering ongoing assistance through in-person or virtual visits and 24-hour phone support
  • Coordinating the delivery of medicine
Accredo Specialty Pharmacy logo
www.accredo.com

Phone: 1-866-344-48741-866-344-4874

Fax: 1-800-711-3526

CVS Specialty Pharmacy logo
www.cvsspecialty.com

Phone: 1-877-242-27381-877-242-2738

Fax: 1-877-943-1000

Treprostinil cost assistance

Assist (Access Solutions and Support Team) logo

ASSIST (Access Solutions and Support Team) is a team at United Therapeutics that is committed to helping patients getting started on PAH treatment. ASSIST is available to answer questions about prescriptions, explain insurance coverage, determine eligibility for financial assistance programs, and will coordinate with Specialty Pharmacies.

You can reach an ASSIST Case Manager Monday through Friday, 8:30 AM to 7:00 PM ET, by calling 1-877-864-8437.1-877-864-8437.

Co-Pay Assistance Program

Most eligible patients who enroll can pay as little as $5 co-pay for their treprostinil prescription.

Through the Co-Pay Assistance Program, each eligible patient prescribed a United Therapeutics treatment has options available for potential financial assistance. United Therapeutics can help patients meet out-of-pocket co-pays, allowing most eligible patients who enroll to pay as little as a $5 co-pay for each prescription.

The program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the program. Please review eligibility requirements and additional terms and conditions.

ENROLL NOW

Tyvaso Virtual Patient Educators

UT Archways logo link

Understanding your condition and getting started on treatment with TYVASO (inhaled treprostinil) can leave you with questions.

The United Therapeutics’ Archways program is here to help. Archways is a convenient educational resource and support program for patients who have been prescribed TYVASO and their caregivers. Archways offers useful information about your condition and treatment with TYVASO—plus it gives you the opportunity to talk one-on-one with a United Therapeutics Patient Educator over the phone or via video chat.

United Therapeutics and the Archways program do not provide medical advice. You are advised to consult with your healthcare provider with any specific questions or concerns about your treatment.

Getting started

You must enroll in the Archways program to participate. In order to enroll in the Archways program, you must have a diagnosis of PAH as well as a prescription for Tyvaso.

To get started and to learn more about how the United Therapeutics Virtual Patient Educators can help:

Stay informed

Enroll in our program to receive updates and PAH information.

SIGN UP NOW

Find a specialist

Use this tool to locate a specialist in your area who can help treat PAH.

SEARCH NOW

PAH=pulmonary arterial hypertension; PH=pulmonary hypertension.

This website uses cookies to ensure you get the best experience on our website. Learn more.

Treatment options for adult patients with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs.

  • ORENITRAM is a prescription medication shown to delay the progression of PAH and improve your ability to exercise.
  • TYVASO is a prescription medicine that can improve your ability to exercise.
  • REMODULIN is a prescription medicine that can reduce symptoms associated with exercise. In patients who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.

Treatment options for adult patients with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs.

  • ORENITRAM is a prescription medication shown to delay the progression of PAH and improve your ability to exercise.
  • TYVASO is a prescription medicine that can improve your ability to exercise.
  • REMODULIN is a prescription medicine that can reduce symptoms associated with exercise. In patients who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.

What is Orenitram?

Orenitram is a prescription medicine used to treat pulmonary arterial hypertension (PAH) which is high blood pressurein the arteries of your lungs. Orenitram can help slow down the progression of your disease and improve your ability to exercise. It is not known if Orenitram is safe and effective in children.

IMPORTANT SAFETY INFORMATION FOR ORENITRAM

Who should not take Orenitram?

Do not take Orenitram if you have severe liver problems.

What should I tell my healthcare provider before taking Orenitram?

Tell your healthcare provider:

  • If you have liver problems or diverticulosis.
  • If you are pregnant, breastfeeding, and/or plan to become pregnant or breastfeed. It is not known if Orenitram will harm your unborn baby or if Orenitram passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with Orenitram.
  • About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Orenitram and other medicines may affect each other causing side effects. Do not start any new medicine until you check with your healthcare provider. Especially tell your healthcare provider if you take another medicine that contains treprostinil, such as Remodulin® or Tyvaso®.

How should I take Orenitram?

  • Do not change your dose or suddenly stop taking Orenitram without first talking to your healthcare provider.
  • Orenitram is usually taken 3 times a day (about every 8 hours) or 2 times a day (about every 12 hours). Your healthcare provider will tell you how often you should take Orenitram. If you have side effects, your healthcare provider may tell you to change your dose or when you take Orenitram. Take Orenitram with food.
  • Swallow Orenitram tablets whole. Do not split, chew, crush, or break your Orenitram tablets. Do not take Orenitram tablets that are damaged or broken. If Orenitram tablets are not taken whole, they may release too much medicine at one time. This can lead to side effects.
  • If you miss your dose of Orenitram, take the missed dose as soon as possible with food.
  • If you miss 2 or more doses of Orenitram, call your healthcare provider to see if you need to change your dose.
  • If you take too much Orenitram, call your healthcare provider or go to the nearest hospital emergency room right away.
  • You may see the tablet shell in your stools (bowel movements). This is usually normal. The tablet shell is not digested. If you have diverticulosis, the tablet shell may get stuck in a blind pouch or diverticulum in your intestine.

What are the possible side effects of Orenitram?

Orenitram can cause serious side effects, including worsening of PAH symptoms.

  • Stopping Orenitram suddenly may cause worsening of your PAH symptoms. Do not change your dose or suddenly stop taking Orenitram without first talking to your healthcare provider.
  • The most common side effects of Orenitram include headache, diarrhea, nausea, vomiting, flushing, and pain in arms, legs, and jaw. These are not all of the possible side effects of Orenitram. Tell your healthcare provider if you have any side effect that bothers you or does not go away.
  • Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

The risk information provided here is not comprehensive. To learn more about Orenitram, talk with your healthcare provider. Please see Full Prescribing Information and Patient Information at orenitram.com or call Customer Service at 1-877-UNITHER (1-877-864-8437).

OREISIconOCT19

What is TYVASO?

TYVASO (treprostinil) is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. TYVASO can improve the ability to exercise. Your ability to exercise decreases 4 hours after taking TYVASO. It is not known if TYVASO is safe and effective in children under 18 years of age.

IMPORTANT SAFETY INFORMATION FOR TYVASO

Before you take TYVASO, tell your healthcare provider about all of your medical conditions, including if you:

  • Have low blood pressure
  • Have bleeding problems
  • Are pregnant or plan to become pregnant. It is not known if TYVASO will harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if TYVASO passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with TYVASO.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TYVASO and other medicines may affect each other.

Especially tell your healthcare provider if you take:

  • Medicines used to treat high blood pressure or heart disease
  • Medicines that decrease blood clotting (anticoagulants)
  • Water pills (diuretics)
  • Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)

What are the possible side effects of TYVASO?

TYVASO can cause serious side effects, including:

  • Low blood pressure (symptomatic hypotension). If you have low blood pressure, TYVASO may lower your blood pressure more.
  • Bleeding problems. TYVASO may increase the risk of bleeding, especially in people who take blood thinners (anticoagulants).

The most common side effects of TYVASO are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness, and diarrhea. These are not all the possible side effects of TYVASO. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

The risk information provided here is not comprehensive. To learn more about TYVASO, talk with your healthcare provider. Please see Full Prescribing Information, the TD-100 and TD-300 TYVASO® Inhalation System Instructions for Use manuals, and other additional information at www.tyvaso.com or call 1-877-UNITHER (1-877-864-8437).

TYVISIconAPR2021(PAH)

What is Remodulin?

Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin issafe and effective in children.

In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.

IMPORTANT SAFETY INFORMATION FOR REMODULIN

Before you take Remodulin, tell your healthcare provider if you:

  • Have other medical conditions or take other medicines that may affect your use of Remodulin by increasing the risk of side effects or decreasing the drug’s effectiveness.
  • Have liver or kidney problems. Your Remodulin dose may need to be adjusted if you have liver problems.
  • Have low blood pressure or bleeding problems.
  • Are taking gemfibrozil (for high cholesterol), rifampin (for infection) or other drugs that affect liver enzymes. Your doctor may need to adjust your Remodulin dosage.
  • Are pregnant, breastfeeding, or planning to become pregnant. It is not known if Remodulin will harm your unborn baby or if Remodulin passes into your breast milk.

What are the serious side effects of Remodulin?

  • Continuous intravenous (IV) infusions of Remodulin delivered using an external infusion pump, with a tube placed in a central vein within the chest, are associated with the risk of blood stream infections and sepsis, which may be fatal. Therefore, continuous subcutaneous (SC) infusion delivered just beneath the skin is the preferred type of delivery.
  • Worsening of PAH symptoms. Do not stop taking or greatly reduce your Remodulin dose without consulting your doctor.
  • Low blood pressure (symptomatic hypotension). If you have low blood pressure or are taking drugs that lower your blood pressure, the risk of low blood pressure is increased.
  • Bleeding problems. Remodulin may increase the risk of bleeding in people who take blood thinners (anticoagulants).

What are the possible side effects of Remodulin?

  • In clinical studies of SC infusion of Remodulin, most people experienced infusion site pain and infusion site reaction (redness, swelling, and rash). These symptoms were sometimes severe and sometimes required treatment with narcotics or discontinuation of Remodulin.
  • IV infusion of Remodulin delivered through an external pump has been associated with the risk of blood stream infections, arm swelling, tingling sensations, bruising, and pain.
  • The most common side effects seen with either SC or IV Remodulin were headache, diarrhea, nausea, rash, jaw pain, widening of the blood vessels (vasodilatation), and swelling from fluid retention (edema). These are not all the possible side effects of Remodulin. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

The risk information provided here is not comprehensive. To learn more about Remodulin, talk with your healthcare provider. Please see Full Prescribing Information at www.remodulin.com or call Customer Service at 1-877-UNITHER (1-877-864-8437).

REMISIconOct19